SEC Form 4 · accession 0002021238-26-000012
MapLight Therapeutics, Inc. · MPLT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anatol Kreitzer
Officer — Chief Discovery Officer
Period of report
Aug 17, 2026
Accepted (ET)
Aug 19, 2026 · 6:35 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001770069
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Voting Common StockF1,F2 | Aug 17, 2026 | A | 6,020 | $0.00 | A | 180,926 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $11.245 | Aug 17, 2026 | A | 24,455 | A | — | Aug 16, 2036 | Voting Common Stock | 24,455 | 24,455 | D |
Explanation of responses
- F1Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on July 1, 2027, and 1/16th of the RSUs shall vest on each subsequent October 1, January 1, April 1 and July 1 thereafter, subject to the Reporting Person's continued service through each vesting date.
- F2Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
- F31/4th of the total shares underlying the option shall vest on July 1, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.